Inflammatory human leucocyte antigen genotypes are not a risk factor in chronic subdural hematoma development

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Inflammatory human leucocyte antigen genotypes are not a risk factor in chronic subdural hematoma development. / Jensen, Thorbjørn Søren Rønn; Fugleholm, Kåre; Ekstrøm, Claus Thorn; Bruunsgaard, Helle.

In: Acta Neurochirurgica, Vol. 165, 2023, p. 2399–2405.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Jensen, TSR, Fugleholm, K, Ekstrøm, CT & Bruunsgaard, H 2023, 'Inflammatory human leucocyte antigen genotypes are not a risk factor in chronic subdural hematoma development', Acta Neurochirurgica, vol. 165, pp. 2399–2405. https://doi.org/10.1007/s00701-023-05745-w

APA

Jensen, T. S. R., Fugleholm, K., Ekstrøm, C. T., & Bruunsgaard, H. (2023). Inflammatory human leucocyte antigen genotypes are not a risk factor in chronic subdural hematoma development. Acta Neurochirurgica, 165, 2399–2405. https://doi.org/10.1007/s00701-023-05745-w

Vancouver

Jensen TSR, Fugleholm K, Ekstrøm CT, Bruunsgaard H. Inflammatory human leucocyte antigen genotypes are not a risk factor in chronic subdural hematoma development. Acta Neurochirurgica. 2023;165:2399–2405. https://doi.org/10.1007/s00701-023-05745-w

Author

Jensen, Thorbjørn Søren Rønn ; Fugleholm, Kåre ; Ekstrøm, Claus Thorn ; Bruunsgaard, Helle. / Inflammatory human leucocyte antigen genotypes are not a risk factor in chronic subdural hematoma development. In: Acta Neurochirurgica. 2023 ; Vol. 165. pp. 2399–2405.

Bibtex

@article{5fcb8004f5ab4f9bb82a303ca259e0a4,
title = "Inflammatory human leucocyte antigen genotypes are not a risk factor in chronic subdural hematoma development",
abstract = "Background: Chronic subdural hematoma (CSDH) pathophysiology has undergone a paradigm shift from being regarded as solely traumatic to be driven mainly by inflammation. Human leucocyte antigen (HLA) is a gene complex involved in antigen processing and presentation to T lymphocytes, thereby mediating the adaptive immune responses. As specific HLA profiles are associated with inflammatory diseases, patients with a specific HLA profile may have a lower threshold for subdural inflammation, and therefore are predisposed for CSDH development. We hypothesized that (1) CSDH patients have a specific HLA profile compared to a Danish background population, and (2) patients with recurrent CSDH have a specific HLA profile compared to CSDH patients without recurrent CSDH. Methods: Three specific HLA class II haplotypes known to drive inflammatory-mediated diseases were determined in 68 patients with CSDH. The distribution of these three haplotypes in our CSDH population was compared to a Danish population of blood donors using Monte Carlo Pearson{\textquoteright}s chi-square test. Furthermore, the distribution of the haplotypes was compared between CSDH patients with and without recurrent CSDH. Results: We found no significant association between either of the haplotypes and the risk of CSDH, and neither of the haplotypes were associated with increased risk of CSDH recurrence. Conclusion: This study did not show an association between selected HLA class II haplotypes and the risk of CSDH or recurrence of CSDH compared with a healthy background population.",
keywords = "Chronic subdural hematoma, Genetic disposition, Human leucocyte antigen",
author = "Jensen, {Thorbj{\o}rn S{\o}ren R{\o}nn} and K{\aa}re Fugleholm and Ekstr{\o}m, {Claus Thorn} and Helle Bruunsgaard",
note = "Publisher Copyright: {\textcopyright} 2023, The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.",
year = "2023",
doi = "10.1007/s00701-023-05745-w",
language = "English",
volume = "165",
pages = "2399–2405",
journal = "Acta Neurochirurgica",
issn = "0001-6268",
publisher = "Springer Wien",

}

RIS

TY - JOUR

T1 - Inflammatory human leucocyte antigen genotypes are not a risk factor in chronic subdural hematoma development

AU - Jensen, Thorbjørn Søren Rønn

AU - Fugleholm, Kåre

AU - Ekstrøm, Claus Thorn

AU - Bruunsgaard, Helle

N1 - Publisher Copyright: © 2023, The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

PY - 2023

Y1 - 2023

N2 - Background: Chronic subdural hematoma (CSDH) pathophysiology has undergone a paradigm shift from being regarded as solely traumatic to be driven mainly by inflammation. Human leucocyte antigen (HLA) is a gene complex involved in antigen processing and presentation to T lymphocytes, thereby mediating the adaptive immune responses. As specific HLA profiles are associated with inflammatory diseases, patients with a specific HLA profile may have a lower threshold for subdural inflammation, and therefore are predisposed for CSDH development. We hypothesized that (1) CSDH patients have a specific HLA profile compared to a Danish background population, and (2) patients with recurrent CSDH have a specific HLA profile compared to CSDH patients without recurrent CSDH. Methods: Three specific HLA class II haplotypes known to drive inflammatory-mediated diseases were determined in 68 patients with CSDH. The distribution of these three haplotypes in our CSDH population was compared to a Danish population of blood donors using Monte Carlo Pearson’s chi-square test. Furthermore, the distribution of the haplotypes was compared between CSDH patients with and without recurrent CSDH. Results: We found no significant association between either of the haplotypes and the risk of CSDH, and neither of the haplotypes were associated with increased risk of CSDH recurrence. Conclusion: This study did not show an association between selected HLA class II haplotypes and the risk of CSDH or recurrence of CSDH compared with a healthy background population.

AB - Background: Chronic subdural hematoma (CSDH) pathophysiology has undergone a paradigm shift from being regarded as solely traumatic to be driven mainly by inflammation. Human leucocyte antigen (HLA) is a gene complex involved in antigen processing and presentation to T lymphocytes, thereby mediating the adaptive immune responses. As specific HLA profiles are associated with inflammatory diseases, patients with a specific HLA profile may have a lower threshold for subdural inflammation, and therefore are predisposed for CSDH development. We hypothesized that (1) CSDH patients have a specific HLA profile compared to a Danish background population, and (2) patients with recurrent CSDH have a specific HLA profile compared to CSDH patients without recurrent CSDH. Methods: Three specific HLA class II haplotypes known to drive inflammatory-mediated diseases were determined in 68 patients with CSDH. The distribution of these three haplotypes in our CSDH population was compared to a Danish population of blood donors using Monte Carlo Pearson’s chi-square test. Furthermore, the distribution of the haplotypes was compared between CSDH patients with and without recurrent CSDH. Results: We found no significant association between either of the haplotypes and the risk of CSDH, and neither of the haplotypes were associated with increased risk of CSDH recurrence. Conclusion: This study did not show an association between selected HLA class II haplotypes and the risk of CSDH or recurrence of CSDH compared with a healthy background population.

KW - Chronic subdural hematoma

KW - Genetic disposition

KW - Human leucocyte antigen

U2 - 10.1007/s00701-023-05745-w

DO - 10.1007/s00701-023-05745-w

M3 - Journal article

C2 - 37550524

AN - SCOPUS:85166910530

VL - 165

SP - 2399

EP - 2405

JO - Acta Neurochirurgica

JF - Acta Neurochirurgica

SN - 0001-6268

ER -

ID: 362681598